No connection

Search Results

BHST

BEARISH
$4.28 Live
BioHarvest Sciences Inc. · NASDAQ
Target $12.75 (+197.9%)
$4.1 52W Range $12.8

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 03, 2026
Market cap
$97.01M
P/E
N/A
ROE
-83.2%
Profit margin
-32.3%
Debt/Equity
0.55
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
BHST shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.

Key Strengths

Strong revenue growth of 24.6%

Key Risks

Low profit margin of -32.3%
Weak financial trend (Piotroski F-Score: 1/9)
Weak ROE of -83.2%

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
35
Weak
Value
50
Future
65
Past
30
Health
30
Dividend
0
AI Verdict
BHST shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.
Key drivers: Strong revenue growth of 24.6%, Low profit margin of -32.3%, Weak financial trend (Piotroski F-Score: 1/9)
Confidence
35%
Value
50/100

Rule-based valuation (P/E + Graham).

Positives
  • Insufficient data for clear positives.
Watchpoints
No urgent risks highlighted.
Future
65/100

Rule-based growth outlook.

Positives
  • Revenue growth running at 24.6%.
Watchpoints
No urgent risks highlighted.
Past
30/100

Historical performance + price trend: Shares moved -72.5% over 5Y and -30.4% over 1Y.

Positives
  • Insufficient data for clear positives.
Watchpoints
  • ROE only -83.2%.
  • Thin profit margins.
Health
30/100

Balance sheet & liquidity (Z-Score: N/A).

Positives
  • Insufficient data for clear positives.
Watchpoints
No urgent risks highlighted.
Dividend
0/100

Dividend policy fallback.

Positives
  • Insufficient data for clear positives.
Watchpoints
  • No regular dividend payments.

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$4.28
Analyst Target
$12.75
Upside/Downside
+197.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BHST and closest competitors.

Updated 2026-04-02
BHS
BioHarvest Sciences Inc.
Primary
5Y
-72.5%
3Y
-17.9%
1Y
-30.4%
6M
-53.5%
1M
-2.7%
1W
-0.9%
TWG
Top Wealth Group Holding Limited
Peer
5Y
-97.6%
3Y
-97.6%
1Y
-70.1%
6M
-42.8%
1M
-1.3%
1W
+4.8%
ISP
Ispire Technology Inc.
Peer
5Y
-76.8%
3Y
-76.2%
1Y
-50.8%
6M
-20.4%
1M
-9.8%
1W
+2.3%
FTL
FitLife Brands, Inc.
Peer
5Y
+146.8%
3Y
+17.9%
1Y
-17.9%
6M
-51.6%
1M
-32.4%
1W
-7.0%
SOW
Sow Good Inc.
Peer
5Y
-95.2%
3Y
-92.5%
1Y
-50.0%
6M
-59.5%
1M
-31.8%
1W
-21.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
190.22
PEG Ratio
N/A
P/B Ratio
3.6
P/S Ratio
2.81
EV/Revenue
2.41
EV/EBITDA
-21.07
Market Cap
$97.01M

Profitability

Profit margins and return metrics

Profit Margin -32.27%
Operating Margin -12.37%
Gross Margin 59.34%
ROE -83.17%
ROA -9.59%

Growth

Revenue and earnings growth rates

Revenue Growth +24.6%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.55
Moderate
Current Ratio
3.97
Strong
Quick Ratio
3.38
Excellent
Cash/Share
$1.08

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
57.6%
Op. Margin
-12.4%
Net Margin
-24.3%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.87x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
129%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-14
$N/A
2026-03-31
$-0.1
+4.8% surprise
2025-11-13
$-0.14
-21.7% surprise
2025-08-11
$-0.24
-123.3% surprise

Consumer Defensive Sector Comparison

Comparing BHST against 170 companies in the Consumer Defensive sector (9 bullish, 60 neutral, 101 bearish)
Return on Equity (ROE)
-83.17%
This Stock
vs
-13.91%
Sector Avg
+497.7% (Excellent)
Profit Margin
-32.27%
This Stock
vs
-7.77%
Sector Avg
+315.2% (Superior)
Debt to Equity
0.55
This Stock
vs
1.89
Sector Avg
-70.6% (Less Debt)
Revenue Growth
24.6%
This Stock
vs
111.74%
Sector Avg
-78.0% (Slower)
Current Ratio
3.97
This Stock
vs
2.29
Sector Avg
+73.2% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Levy (Yehesket)
Director of Issuer
Stock Award
2026-03-03
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
4 analysts
Roth Capital
2026-02-19
init
Buy

Past News Coverage

Recent headlines mentioning BHST from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile